COMMUNIQUÉS West-GlobeNewswire

Editas Medicine to Present New Data Demonstrating Progress Towards Creating Genome Editing Medicines at the American Society of Gene & Cell Therapy Annual Meeting

30/04/2018 - 19:30

Oral presentation of tolerability and immunogenicity data from a study of EDIT-101 following subretinal injection in non-human primates CAMBRIDGE, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ [...]

AB Science reports today its annual financials as of 31 December 2017 and provides an update on its activities

30/04/2018 - 18:40

Paris, April 30, 2018 - 6.30pm 2017 revenues of 1,739 K€, an increase of 15.3% compared with 2016 Cash position of 38.8M€ as of 31 December 2017, plus 6.6M€ of 2017 tax credit to be reimbursed by the Public Finance [...]

AB Science annonce aujourd'hui ses résultats financiers annuels arrêtés au 31 décembre 2017 et présente l'actualité de ses activités

30/04/2018 - 18:40

Paris, le 30 avril 2018 - 18h30 Chiffre d'affaires de 1 739 K€ pour l'année 2017, en hausse de 15,3% par rapport à 2016 Trésorerie de 38,8M€ au 31 décembre 2017, à laquelle s'ajoutent 6,6M€ de crédit d'impôt 2017 en [...]

Novo Nordisk A/S - Total number of voting rights and share capital in Novo Nordisk A/S as of 30 April 2018

30/04/2018 - 18:37

Bagsværd, Denmark, 30 April 2018 - In accordance with Section 10 of the Danish Statutory Order on Issuers' Disclosure Obligations, Novo Nordisk is required to publish the total number of voting rights and the size of [...]

Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy 2018 Annual Meeting

30/04/2018 - 18:15

Five oral presentations and 10 poster presentations focus on Voyager’s clinical and preclinical programs, novel capsid optimization efforts and manufacturing capabilities Investor and analyst breakfast event at ASGCT [...]

Report on Annual General Meeting of NeuroSearch A/S

30/04/2018 - 18:07

Announcement 30 April 2018 At the company’s Annual General Meeting held today, the following resolutions were passed: The Annual Report for 2017 was approved The Board of Directors' proposal regarding the transfer of [...]

Ossur Hf : Transactions in relation to share buyback program

30/04/2018 - 18:01

Announcement no. 33/2018 Reykjavik, 30 April 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]

UPDATE – Imaging3 Announces Appointment of George Zdasiuk to Board of Directors

30/04/2018 - 17:32

Former CTO of Varian Medical Systems will also chair Imaging3 Scientific Advisory Board BURBANK, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- Imaging 3 , Inc. (OTCQB:IGNG), a development stage company introducing [...]

CyberFuels Inc. Announces Major Expansion of US Retail Outlets for Gasoline and CyberFuels’ Proprietary EcoFlex Blends

30/04/2018 - 17:17

PALM BEACH GARDENS, Fla., April 30, 2018 (GLOBE NEWSWIRE) -- EncounterCare Solutions Inc.'s (Pink sheets:ECSL) wholly owned subsidiary CyberFuels, Inc. is pleased to announce that CyberFuels has signed a contract with [...]

Amedisys Announces First Quarter Earnings Release and Conference Call Date

30/04/2018 - 17:00

BATON ROUGE, La., April 30, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED ), announced today that it will report results for the first quarter ended March 31, 2018 after the market closes on May 7, 2018. The [...]

Repligen to Report First Quarter 2018 Financial Results

30/04/2018 - 17:00

- Webcast and Conference Call to Be Held Tuesday, May 8, 2018 at 8:30 a.m. EDT - WALTHAM, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN ) today announced that the Company will report its [...]

Accelerate Diagnostics to Review First Quarter 2018 Results on May 9th

30/04/2018 - 16:42

TUCSON, Ariz., April 30, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Wednesday, May 9, 2018 to review its first quarter 2018 financial results and commercial [...]

Eckert & Ziegler BEBIG: Annual Report 2017 published

30/04/2018 - 16:42

Regulated Information Seneffe - Belgium, April 30, 2018 - Eckert & Ziegler BEBIG (Euronext: EZBG; Reuters: EZBG.BR; Bloomberg: EZBG:BB) announced today that its annual financial report for the year ending December [...]

Eckert & Ziegler BEBIG: Publication du Rapport Annuel 2017

30/04/2018 - 16:42

Information réglementée Seneffe - Belgium, le 30 avril 2018 - Eckert & Ziegler BEBIG (Euronext: EZBG; Reuters: EZBG.BR; Bloomberg: EZBG:BB) a communiqué aujourd'hui que son rapport annuel financier pour l'année se [...]

Analogic Receives Early Termination of HSR Waiting Period

30/04/2018 - 16:30

PEABODY, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- Analogic Corporation (NASDAQ: ALOG ) (“the Company” or “Analogic”), a provider of leading-edge healthcare and security solutions, announced that it has received notice [...]

ALAVIDA HEALTH Secures Third Round of Funding

30/04/2018 - 16:28

Company Offers Alternative Treatment for Problem Drinking with a 75% Success Rate VANCOUVER, British Columbia, April 30, 2018 (GLOBE NEWSWIRE) -- Alavida Health , a science-based remote treatment program for Alcohol Use [...]

Orion Corporation: Managers' transactions - Agendum Oy

30/04/2018 - 16:15

ORION CORPORATION MANAGERS' TRANSACTIONS 30 APRIL 2018 at 17.15 EEST Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked [...]

Bavarian Nordic A/S - Articles of Association

30/04/2018 - 16:06

Updated Articles of Association for Bavarian Nordic A/S Attachment BavarianNordicArticlesofAssociation.pdf

Medtronic Announces FDA Approval of Infuse(TM) Bone Graft in New Spine Surgery Indications Using PEEK Interbody Implants

30/04/2018 - 16:00

Approval Adds Two Additional Implants to Current Spine Labeling DUBLIN - April 30, 2018 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of Infuse(TM) Bone Graft in new spine [...]